Medical Oncologist
Biomarker & Molecular Testing
Cost of NGS and Mutation Testing — India 2026 Price Guide
NGS testing costs depend almost entirely on how many genes are checked. A small hotspot panel costs a fraction of a large comprehensive panel — and ordering the right size for your situation is the decision that matters most.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Size drives cost — A 50-gene panel and a 500-gene panel are not the same test. Knowing which one your oncologist actually needs prevents overspending.
- Results take time — Most panels take 10 to 21 days. If a treatment decision is urgent, ask about turnaround before you book.
- Indicative prices only — Published prices vary by laboratory and city. The figures here are 2026 indicative ranges to help you budget and compare.
- Your oncologist decides — The right panel is the one your oncologist specifies. A larger panel is not automatically better.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
NGS testing in India costs roughly ₹8,000 to over ₹80,000 in 2026, depending on how many genes are tested. Results typically take 10 to 21 days. Your oncologist decides which panel size is right for your cancer type — ordering the wrong size wastes both money and time.
How much does NGS testing cost in India, and how long does it take?
Small hotspot panels — testing between 5 and 50 genes — cost roughly ₹8,000 to ₹15,000 and return results in 10 to 14 days. These are used when your oncologist is looking for one or two specific mutations.
Mid-size panels testing 50 to 300 genes typically cost ₹20,000 to ₹45,000 and take 14 to 18 days. These are the most commonly ordered panels for solid tumours in India.
Large comprehensive panels covering more than 300 genes range from ₹50,000 to over ₹80,000 and take 18 to 21 days. These are ordered when a broader search is needed — for example, after targeted therapy has stopped working.
All figures are indicative for 2026 and vary by laboratory and city. Ask for a written quote before the sample is sent.
What is the difference between a small gene panel and a large one?
| Feature | Hotspot / Small panel | Mid-size panel | Large comprehensive panel |
|---|---|---|---|
| Genes tested | 5–50 | 50–300 | 300–500+ |
| Indicative cost (2026) | ₹8,000–₹15,000 | ₹20,000–₹45,000 | ₹50,000–₹80,000+ |
| Typical turnaround | 10–14 days | 14–18 days | 18–21 days |
| Best suited for | Looking for one specific mutation; urgent treatment start | First-line planning for common solid tumours | Resistant disease; rare cancers; clinical trial eligibility |
| Main limitation | Misses mutations outside the tested genes | May not cover all emerging targets | Higher cost and longer wait; not always necessary |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
How do I know which NGS panel is right for me?
Start here: has your oncologist named a specific gene or mutation to look for? If yes, a small hotspot panel — 5 to 50 genes — is usually all that is needed.
If no specific gene has been named and this is your first treatment plan for a solid tumour such as lung, colorectal, breast, or gastric cancer, a mid-size panel covering 50 to 300 genes is the usual starting point.
If a targeted therapy has already stopped working, or if your cancer is rare and your oncologist wants to search broadly for any actionable change, a large comprehensive panel covering 300 or more genes is more likely to give useful information.
If none of these situations fits, ask your oncologist directly: what question is this test trying to answer? The answer to that question determines the panel size — not the price and not the brand.
Did you know?
The same NGS panel can cost significantly different amounts across laboratories in India, even within the same city. NABL and CAP accreditation are the two quality markers worth asking about when comparing quotes — both indicate the laboratory meets internationally validated standards for accuracy.
Price alone is not a reliable guide to quality.
Source: National Accreditation Board for Testing and Calibration Laboratories (NABL); College of American Pathologists (CAP)
Explore 119 more Targeted Therapy Basics, Testing & Your Cancer Type topics
Biomarker & Molecular Testing
- Can Mutation Testing Be Done on an Old Biopsy Block or Slides?
- Cost of NGS and Mutation Testing in India: 2026 Price Guide
- Do I Need Genetic Testing Before Starting Targeted Therapy?
- Germline vs Somatic Testing: The Difference Nobody Explains Properly
- Getting a Second Opinion on Your Genomic Report
- How Long Do Mutation Test Results Take in India? Realistic Timelines
- How to Read Your Molecular Pathology Report, Line by Line
- IHC, FISH, PCR or NGS: Which Mutation Test Is Right for Your Cancer?
- Is Mutation Testing Worth It If I Can't Afford the Drug?
- Liquid Biopsy vs Tissue Biopsy: Which Test Do You Need?
- My Report Says a Mutation Is 'Actionable': What Does That Mean?
- No Mutation Found in My Report: What Are My Options Now?
- Should I Start Chemotherapy While Waiting for Mutation Results?
- Should You Repeat Molecular Testing After Your Cancer Progresses?
- Single-Gene Test or Full Panel? How to Choose Without Wasting Money
- What Are PD-L1, TMB and MSI, and Do They Affect Targeted Therapy?
- What Does 'Variant of Uncertain Significance' (VUS) Mean?
- What Happens If There Isn't Enough Tissue for Mutation Testing?
- What Is NGS (Next-Generation Sequencing) Testing in Cancer?
- What Is a Molecular Tumour Board and Why Should You Want One?
- Which Cancers Should Always Be Tested for Mutations? A Checklist
- ctDNA and MRD Testing: Tracking Cancer Through a Blood Test
Before You Start - Preparation & Baseline
- 25 Questions to Ask Your Oncologist Before Starting Targeted Therapy
- Before You Start Targeted Therapy: The Complete Preparation Checklist
- Dental Check-Up Before Cancer Treatment: Why It Matters
- Financial Planning Before Starting Long-Term Targeted Therapy
- How Long After Surgery Can You Start Targeted Therapy?
- How to Store Your Targeted Therapy Tablets Correctly
- Setting Up a Dosing Routine You Won't Forget
- Should Targeted Therapy Be Taken With Food or on an Empty Stomach?
- Vaccinations Before and During Cancer Treatment
- What to Expect in Your First Month on Targeted Therapy
- Which Baseline Tests Are Done Before Starting a TKI?
- Which of Your Existing Medicines Must Stop Before Targeted Therapy
- Why You Need an ECHO and ECG Before Certain Cancer Drugs
Cancer-Type Specific Targeted Therapy
- CML Treatment with TKIs: Living a Normal Life Span
- Cancer of Unknown Primary: Can Molecular Testing Help?
- GIST Treatment: Why This Cancer Changed Targeted Therapy Forever
- Targeted Therapy for Bile Duct Cancer (Cholangiocarcinoma)
- Targeted Therapy for Bladder and Urothelial Cancer
- Targeted Therapy for Brain Tumours and Glioma
- Targeted Therapy for Breast Cancer: HER2, HR+ and Triple Negative
- Targeted Therapy for CLL and Lymphoma
- Targeted Therapy for Cervical and Endometrial Cancer
- Targeted Therapy for Childhood Cancers
- Targeted Therapy for Colorectal Cancer: RAS, BRAF and HER2
- Targeted Therapy for Head and Neck Cancer
- Targeted Therapy for Kidney Cancer (RCC)
- Targeted Therapy for Liver Cancer (HCC)
- Targeted Therapy for Lung Cancer: Every Mutation and Drug Explained
- Targeted Therapy for Melanoma: BRAF and MEK Inhibitors
- Targeted Therapy for Multiple Myeloma
- Targeted Therapy for Neuroendocrine Tumours
- Targeted Therapy for Ovarian Cancer: PARP Inhibitors and Beyond
- Targeted Therapy for Pancreatic Cancer: Limited but Real Options
- Targeted Therapy for Prostate Cancer
- Targeted Therapy for Sarcoma
- Targeted Therapy for Stomach and Gastroesophageal Cancer
- Targeted Therapy for Thyroid Cancer
- Targeted Therapy in AML: Beyond Standard Chemotherapy
- Tumour-Agnostic Drugs: When the Mutation Matters More Than the Organ
Foundations & How Targeted Therapy Works
- Adjuvant and Neoadjuvant Targeted Therapy: Treatment Before or After Surgery
- Antibody-Drug Conjugates (ADCs): The Smart Bombs of Cancer Treatment
- Biosimilars and Generic Targeted Therapy Drugs: What They Are
- Can Targeted Therapy Be Combined with Chemotherapy or Radiation?
- Can Targeted Therapy Cure Cancer? An Honest Answer
- First-Line, Second-Line and Beyond: How Treatment Lines Work
- How Doctors Decide Between Chemo, Immunotherapy and Targeted Therapy
- How Does Targeted Therapy Actually Work? Explained Without Jargon
- How Long Does Targeted Therapy Take to Start Working?
- Is Targeted Therapy Painful? What the Treatment Actually Feels Like
- Is Targeted Therapy a Type of Chemotherapy? Clearing Up the Confusion
- Oral Tablets vs IV Infusion Targeted Therapy: What's the Difference?
- Precision Oncology vs Personalised Medicine: Are They the Same Thing?
- Targeted Therapy Success Rates: What the Numbers Really Mean
- Targeted Therapy for Stage 4 Cancer: What You Can Realistically Expect
- Targeted Therapy vs Chemotherapy: 12 Differences That Actually Matter
- Targeted Therapy vs Immunotherapy: Which One Is Right for You?
- The 8 Main Types of Targeted Therapy Drugs (With Examples)
- What Do Cancer Drug Endings Like -nib, -mab and -tinib Mean?
- What Is Targeted Therapy for Cancer? A Complete Patient Guide
- Which Cancers Can Be Treated with Targeted Therapy? Full List
- Why Didn't My Doctor Recommend Targeted Therapy for Me?
Mutation & Target-Specific Pages
- ALK-Positive Lung Cancer: Drugs, Response and What Comes Next
- Antiangiogenic Drugs (VEGF Inhibitors): How Starving a Tumour Works
- BCR-ABL and the Philadelphia Chromosome in CML
- BRAF V600E Mutation: Targeted Therapy Across Multiple Cancers
- BRCA vs HRD Testing: Which One Determines PARP Inhibitor Eligibility?
- BRCA1 and BRCA2 Mutations in Cancer Treatment: PARP Inhibitors
- BTK Inhibitors in CLL and Lymphoma
- CD20, CD38 and Other Antibody Targets in Blood Cancers
- CDK4/6 Inhibitors in Hormone-Positive Breast Cancer
- Co-Mutations: When You Have Two Mutations at Once
- EGFR Exon 20 Insertion: Why It's Different and Harder to Treat
- EGFR Mutation in Lung Cancer: Complete Patient Guide
- ESR1 Mutation: Why Your Hormone Therapy Stopped Working
- FGFR Alterations in Bladder and Bile Duct Cancer
- FLT3 Mutation in AML: What It Means for Your Prognosis
- HER2 Mutation in Lung and Gastric Cancer
- HER2-Low Breast Cancer: A New Category That Changes Treatment
- HER2-Positive Breast Cancer: The Full Targeted Therapy Roadmap
- IDH1 and IDH2 Mutations in Glioma, AML and Bile Duct Cancer
- KIT and PDGFRA Mutations in GIST
- KRAS G12C Mutation: The Target That Was Undruggable for 40 Years
- KRAS Mutation but Not G12C: What Are My Options?
- MET Exon 14 Skipping and MET Amplification Explained
- MSI-High and Mismatch Repair Deficiency: Testing and Treatment
- NRG1, MET, RET and Other Rare Fusions: Where to Get Tested
- NTRK Fusion: One Drug for Many Different Cancers
- Osimertinib: What to Expect, Side Effects and How Long It Works
- PALB2, ATM and Other BRCA-Like Genes: Do They Get the Same Drugs?
- PIK3CA Mutation in Breast Cancer: Alpelisib and What to Expect
- PSMA and AR-Targeted Therapy in Prostate Cancer
- RET Fusion Cancer: Lung, Thyroid and Beyond
- ROS1-Positive Cancer: A Rare Mutation with Excellent Options
- TP53 Mutation: Why There's Still No Targeted Drug for It
- Understanding Variant Allele Frequency (VAF) in Your Report
- What If My Mutation Has No Approved Drug Yet?
- mTOR Inhibitors in Cancer: Everolimus and Temsirolimus
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Is NGS testing covered by health insurance in India?
Coverage varies widely — some insurers cover NGS under a broad diagnostic benefit; others do not cover it at all or require pre-authorisation with a specific clinical indication. Check with your insurer before the sample is sent, not after. Ask your oncology team to provide the clinical justification in writing, because insurers often need the oncologist's rationale alongside the test request to approve the claim.
Do we need a new biopsy, or can we use the sample we already have?
In most cases, the archived biopsy tissue — the FFPE block or slides from your original diagnosis — is sufficient for NGS testing, and you do not need a new procedure. Ask your oncologist to arrange transfer of the block to the testing laboratory. If the sample is old, very small, or of poor quality, the laboratory may advise a liquid biopsy or a repeat biopsy instead.
What is liquid biopsy and is it cheaper than tissue NGS?
Liquid biopsy tests circulating tumour DNA from a blood sample rather than tissue — it is less invasive and avoids the need for a new biopsy procedure. Indicative costs in 2026 are broadly similar to mid-size tissue panels. Results can be harder to interpret when the tumour is not shedding much DNA into the blood. Your oncologist will tell you whether it is a suitable alternative in your situation.
What happens if the NGS report finds no actionable mutation?
A non-actionable result is still useful information. It tells your oncologist that targeted therapy is unlikely to help and that chemotherapy, immunotherapy, or another approach is more appropriate for your cancer. It does not mean the cancer is untreatable. Ask your oncologist to walk you through the report and explain what the finding means for your specific treatment plan.
Can NGS testing be done at CION?
Yes. At CION, NGS testing is coordinated through accredited partner laboratories, so you do not need to find or approach a laboratory yourself. Your oncologist will advise which panel is appropriate for your cancer type, arrange the sample transfer, and review the report with you when results return. If tissue is already stored at another centre, your oncologist can arrange for it to be transferred.
Should we get a second opinion if the NGS report recommends an expensive targeted therapy?
Yes, and this is a reasonable thing to ask for. A second oncology opinion on the report interpretation — not just on the cost — can confirm whether the recommended treatment is in line with current NCCN, ESMO, or ASCO guidance for your cancer type. Some results are straightforward; others are genuinely debated among oncologists. Knowing which category you are in helps you make an informed decision before committing to a costly treatment course.